Articles by Nicholas Short, MD
In a podcast, experts explore chemo-free ALL therapies, CAR T breakthroughs, and the future of T-cell–targeted treatments.
Nicholas Short, MD, discusses updated results from a phase I/II study of a triplet combination for FLT3-mutated AML.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.